IRONWOOD PHARMACEUTICALS, INC. Inventory Write-down
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Inventory Write-down of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2020-02-13
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for the quarter ending 2019-03-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for the quarter ending 2018-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for fiscal 2018 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for fiscal 2016 was $10.10M, a 0.00% change from fiscal 2015.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for fiscal 2015 was $10.10M, a 50.23% decline from fiscal 2014.
- IRONWOOD PHARMACEUTICALS, INC. inventory write-down for fiscal 2014 was $20.29M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 4 quarters · filed 2019-10-31 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-07-30 | $0.00 10-Q · filed 2019-07-30 | $0.00 derived: sum of 3 quarters · filed 2019-07-30 | $2.50M derived: sum of 4 quarters · filed 2019-10-31 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | $0.00 derived: sum of 2 quarters · filed 2019-05-02 | $2.50M derived: sum of 3 quarters · filed 2019-10-31 | $4.30M derived: sum of 4 quarters · filed 2019-10-31 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $2.50M derived: sum of 2 quarters · filed 2019-10-31 | $4.30M derived: sum of 3 quarters · filed 2019-10-31 | $0.00 10-K · filed 2019-02-25 | ||
| 2018-09-30 | $2.50M 10-Q · filed 2019-10-31 | $0.00 10-Q · filed 2018-11-06 | $4.30M derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $1.80M 10-Q · filed 2019-07-30 | $1.80M derived: sum of 2 quarters · filed 2019-07-30 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | |||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | $10.10M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $10.10M derived: sum of 3 quarters · filed 2020-02-13 | $10.10M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-04 | $10.10M derived: sum of 2 quarters · filed 2020-02-13 | $10.10M derived: sum of 3 quarters · filed 2020-02-13 | $10.10M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2016-12-31 | $10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $10.10M derived: sum of 2 quarters · filed 2020-02-13 | $10.10M derived: sum of 3 quarters · filed 2020-02-13 | $10.10M 10-K · filed 2020-02-13 | $374.00K 10-K · filed 2017-02-22 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |||||
| 2015-12-31 | $10.10M 10-K · filed 2019-02-25 | $17.64M 10-K · filed 2016-02-19 | ||||
| 2015-06-30 | $5.00M 10-K · filed 2018-02-22 | $4.95M 10-K · filed 2016-02-19 | $8.15M 10-Q · filed 2015-08-07 | |||
| 2014-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $11.40M derived: sum of 2 quarters · filed 2017-02-22 | $20.30M derived: sum of 3 quarters · filed 2017-02-22 | $20.29M 10-K · filed 2017-02-22 | ||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-05 | $8.90M derived: sum of 2 quarters · filed 2015-11-05 | $8.89M 10-Q · filed 2014-11-05 | |||
| 2014-06-30 | $8.90M 10-Q · filed 2015-11-05 | $8.89M 10-Q · filed 2015-08-07 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $0.00 10-Q · filed 2014-11-05 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |